Evidence map›Paper›PMID 36283413›Full record

ArticleMolecular cell2022

ATP13A1 prevents ERAD of folding-competent mislocalized and misoriented proteins.

Michael J McKenna, Benjamin M Adams, Vincent Chu, Joao A Paulo, Sichen Shao

Open access · greenAbstract read
In one paragraph

Article in Molecular cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. The structure and function of P5A-ATPases.Nature communications · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. A genome-wide optical pooled screen reveals regulators of cellular antiviral responses.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Michael J McKennaDepartment of Cell Biology, Harvard Medical School, 240 Longwood Ave., Boston, MA 02115, USA.
Benjamin M AdamsDepartment of Cell Biology, Harvard Medical School, 240 Longwood Ave., Boston, MA 02115, USA.
Vincent ChuDepartment of Cell Biology, Harvard Medical School, 240 Longwood Ave., Boston, MA 02115, USA.
Joao A PauloDepartment of Cell Biology, Harvard Medical School, 240 Longwood Ave., Boston, MA 02115, USA.
Sichen ShaoDepartment of Cell Biology, Harvard Medical School, 240 Longwood Ave., Boston, MA 02115, USA. Electronic address: sichen_shao@hms.harvard.edu.
Harvard University · US

Funding

Decoding ribosome-triggered quality control mechanismsDP2GM137415 · NIGMS · HARVARD MEDICAL SCHOOL · PI SHAO, SICHEN · 2019 to 2019
$2.5M
Quality control of mislocalized membrane proteinsR01AG073277 · NIA · HARVARD MEDICAL SCHOOL · PI Sichen Shao · 2022 to 2026
$1.7M
Advancing Multiplexed Isobaric Tag-based Strategies for Proteome ProfilingR01GM132129 · NIGMS · HARVARD MEDICAL SCHOOL · PI PAULO, JOAO A · 2019 to 2023
$1.7M
NIA NIH HHS R01 AG073277NIGMS NIH HHS DP2 GM137415NIGMS NIH HHS R01 GM132129
6 · The paper itself

Abstract

The biosynthesis of thousands of proteins requires targeting a signal sequence or transmembrane segment (TM) to the endoplasmic reticulum (ER). These hydrophobic ɑ helices must localize to the appropriate cellular membrane and integrate in the correct topology to maintain a high-fidelity proteome. Here, we show that the P5A-ATPase ATP13A1 prevents the accumulation of mislocalized and misoriented proteins, which are eliminated by different ER-associated degradation (ERAD) pathways in mammalian cells. Without ATP13A1, mitochondrial tail-anchored proteins mislocalize to the ER through the ER membrane protein complex and are cleaved by signal peptide peptidase for ERAD. ATP13A1 also facilitates the topogenesis of a subset of proteins with an N-terminal TM or signal sequence that should insert into the ER membrane with a cytosolic N terminus. Without ATP13A1, such proteins accumulate in the wrong orientation and are targeted for ERAD by distinct ubiquitin ligases. Thus, ATP13A1 prevents ERAD of diverse proteins capable of proper folding.

Indexed as

Endoplasmic Reticulum-Associated DegradationMembrane ProteinsAdenosine TriphosphatasesAnimalsEndoplasmic ReticulumMammalsMitochondrial ProteinsProtein FoldingProtein Sorting SignalsUbiquitin-Protein LigasesAdenosine TriphosphatasesMembrane ProteinsMitochondrial ProteinsProtein Sorting SignalsUbiquitin-Protein LigasesER-associated degradationprotein localizationprotein topologyquality controlsignal sequencetransmembrane proteins

Identifiers

PMID36283413
PMCPMC9675726
OpenAlexW4307288790

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.